To the Editor:
This Response Letter addresses discussion initiated by Hüttemann et al. in their Letter to the Editor, in response to our manuscript “Ndufs2, a Core Subunit of Mitochondrial Complex I, Is Essential for Acute Oxygen-Sensing and Hypoxic Pulmonary Vasoconstriction”1. We stand by the results presented in the original publication and wish to expand our rationale regarding the screening of COX4I2 in vitro, and further the discussion of pre-clinical models of the complex pulmonary vascular oxygen-sensing mechanism.
Ndufs2 was identified as a candidate oxygen-sensor as a result of over 3 decades of research demonstrating that the Complex I inhibitor rotenone, mimics hypoxic pulmonary vasoconstriction (HPV) and recapitulates the effects of hypoxia in other oxygen-sensing tissues, including type 1 glomus cells of the carotid body2 and adrenomedullary chromaffin cells3. As the quinone binding site within Complex I, Ndufs2 is a primary driver of Complex I activity. It is also the rotenone binding site4 and is both redox-sensitive5 and a target of posttranslationalmodification6. Our finding that Ndufs2 is essential for acute oxygen-sensing in the pulmonary vasculature reinforces previously published work by Fernández-Agüera et al. identifying Ndufs2 as the oxygen-sensor of the carotid body7, as well as the hypothesis that oxygen-sensing tissues have common sensor(s)8. We also made every effort to examine the theories of other groups by screening multiple subunits implicated in pulmonary vascular oxygen-sensing beyond our own hypothesis, including the Riekse Fe-S subunit9 and COX4i210.
We do not believe the COX4i2 data in our original manuscript was misinterpreted, given the information available at the time of publication. While we cannot comment on unpublished data from other groups, we found that an ~50% knockdown of COX4i2 (verified at the gene and protein level with appropriate statistical replicates) did not result in any reduction of HPV, dose-dependent or otherwise.
It is also pertinent to address the importance of modelling robust HPV as well as significant differences in experimental design utilized by various groups. While Sommer et al. presents a thorough examination of COX4i2 in oxygen-sensing, it cannot be ignored that the range for ΔPAP in their acute hypoxia studies spans only 0–1 mmHg10. ΔPAP of 1.0 ± 0.11 mmHg for wild-type mice is far below the previously published hypoxia-induced ΔPAP of ~10 mmHg reported by Schwenke et al.11, and thus it remains difficult to interpret the physiological relevance of this model with such small hypoxic changes in mPAP. Further, since in vitro and in vivo models as well as experimental conditions, including degree of hypoxia, duration of hypoxic exposure, and numerous measurement techniques/assays are not identical, somewhat divergent results with respect to the exact identity of the oxygen-sensor, are not entirely surprising. In the fullness of time, it is likely to be confirmed that all proposed subunits play different roles in pulmonary vascular oxygen-sensing, providing a degree of redundancy similar to that found in other biological systems12.
The evolution of the vascular oxygen-sensing field has resulted in a large degree of consensus: it is widely accepted that the mitochondrion is the oxygen-sensor, that at least one (and likely multiple) electron transport chain protein(s) sense changes in PO2 in a redoxdependent manner, and that mitochondrially-derived reactive oxygen species are the secondary messenger, altering the cellular milieu to stimulate the closing of voltage-gated potassium (Kv) channels, opening of voltage-gated L-type calcium channels, and subsequent vasoconstriction.
In conclusion, we appreciate the concerns raised by Hüttemann et al. and encourage other groups to consider testing the molecular targets identified by their colleagues. Discussing divergent findings in the field of oxygen sensing with curiosity and openness is consistent with the best spirit of scientific debate.
Acknowledgments
Funding: This work was supported by a CIHR Foundation Grant, NIH-R01- HL071115, R01- HL113303, a Tier 1 Canada Research Chair in Mitochondrial Dynamics and the William J Henderson Foundation (S.L. Archer), Canadian Vascular Network (K.J. Dunham-Snary), and a CIHR Postdoctoral Fellowship (K.J. Dunham-Snary).
Footnotes
Disclosures: None.
References
- 1.Dunham-Snary KJ, Wu D, Potus F, Sykes EA, Mewburn JD, Charles RL, Eaton P, Sultanian RA, Archer SL. Ndufs2, a core subunit of mitochondrial complex i, is essential for acute oxygen-sensing and hypoxic pulmonary vasoconstriction. Circ Res. 2019;124:1727–1746 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ortega-Saenz P, Pardal R, Garcia-Fernandez M, Lopez-Barneo J. Rotenone selectively occludes sensitivity to hypoxia in rat carotid body glomus cells. J Physiol. 2003;548:789–800 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Thompson RJ, Buttigieg J, Zhang M, Nurse CA. A rotenone-sensitive site and h2o2 are key components of hypoxia-sensing in neonatal rat adrenomedullary chromaffin cells. Neuroscience. 2007;145:130–141 [DOI] [PubMed] [Google Scholar]
- 4.Darrouzet E, Issartel JP, Lunardi J, Dupuis A. The 49-kda subunit of nadh-ubiquinone oxidoreductase (complex i) is involved in the binding of piericidin and rotenone, two quinone-related inhibitors. FEBS Lett. 1998;431:34–38 [DOI] [PubMed] [Google Scholar]
- 5.Gorenkova N, Robinson E, Grieve DJ, Galkin A. Conformational change of mitochondrial complex i increases ros sensitivity during ischemia. Antioxid Redox Signal. 2013;19:1459–1468 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Carroll J, Ding S, Fearnley IM, Walker JE. Post-translational modifications near the quinone binding site of mammalian complex i. J Biol Chem. 2013;288:24799–24808 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fernandez-Aguera MC, Gao L, Gonzalez-Rodriguez P, Pintado CO, Arias-Mayenco I, Garcia-Flores P, Garcia-Perganeda A, Pascual A, Ortega-Saenz P, Lopez-Barneo J. Oxygen sensing by arterial chemoreceptors depends on mitochondrial complex i signaling. Cell Metab. 2015;22:825–837 [DOI] [PubMed] [Google Scholar]
- 8.Weir EK, Lopez-Barneo J, Buckler KJ, Archer SL. Acute oxygen-sensing mechanisms. N Engl J Med. 2005;353:2042–2055 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Waypa GB, Marks JD, Guzy RD, Mungai PT, Schriewer JM, Dokic D, Ball MK, Schumacker PT. Superoxide generated at mitochondrial complex iii triggers acute responses to hypoxia in the pulmonary circulation. Am J Respir Crit Care Med. 2013;187:424–432 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sommer N, Huttemann M, Pak O, Scheibe S, Knoepp F, Sinkler C, Malczyk M, Gierhardt M, Esfandiary A, Kraut S, et al. Mitochondrial complex iv subunit 4 isoform 2 is essential for acute pulmonary oxygen sensing. Circ Res. 2017;121:424–438 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Schwenke DO, Pearson JT, Mori H, Shirai M. Long-term monitoring of pulmonary arterial pressure in conscious, unrestrained mice. J Pharmacol Toxicol Methods. 2006;53:277–283 [DOI] [PubMed] [Google Scholar]
- 12.Tononi G, Sporns O, Edelman GM. Measures of degeneracy and redundancy in biological networks. Proc Natl Acad Sci U S A. 1999;96:3257–3262 [DOI] [PMC free article] [PubMed] [Google Scholar]
